Alliance Pharma plc Cash Flow Reinvestment Rate
Alliance Pharma plc cash flow reinvestment rate. Alliance Pharma plc (APH) has a Cash Flow Reinvestment Rate of 0.01x as of December 2024, reinvesting GBX113.00K (capex GBX113.00K ) from operating cash flow of GBX20.47 Million. Explore APH cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Alliance Pharma plc (1999–2024)
Cash flow reinvestment rate of Alliance Pharma plc from 1999 to 2024. Historical reinvestment intensity for Alliance Pharma plc across 23 annual periods. Explore Alliance Pharma plc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Alliance Pharma plc Cash Flow Reinvestment Rate by Year (1999–2024)
Alliance Pharma plc cash flow reinvestment rate by year from 1999 to 2024. Year-by-year capital reinvestment analysis for Alliance Pharma plc. For the full cash flow conversion analysis, see cash flow conversion of Alliance Pharma plc.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.07x | GBX2.90 Million | GBX38.72 Million | GBX841.00K | ▲ +45.6% |
| 2023 | 0.05x | GBX1.61 Million | GBX31.41 Million | GBX696.00K | ▼ -93.9% |
| 2022 | 0.84x | GBX17.63 Million | GBX20.97 Million | GBX607.00K | ▲ +220.8% |
| 2021 | 0.26x | GBX10.13 Million | GBX38.66 Million | GBX5.53 Million | ▼ -88.0% |
| 2020 | 2.18x | GBX90.48 Million | GBX41.57 Million | GBX4.61 Million | ▲ +1571.3% |
| 2019 | 0.13x | GBX4.66 Million | GBX35.76 Million | GBX4.16 Million | ▼ -43.7% |
| 2018 | 0.23x | GBX5.13 Million | GBX22.17 Million | GBX2.93 Million | ▲ +25.8% |
| 2017 | 0.18x | GBX4.89 Million | GBX26.58 Million | GBX2.69 Million | ▼ -67.0% |
| 2016 | 0.56x | GBX9.43 Million | GBX16.93 Million | GBX1.40 Million | ▼ -96.7% |
| 2015 | 17.11x | GBX136.48 Million | GBX7.98 Million | GBX134.28 Million | ▲ +5508.6% |
| 2014 | 0.31x | GBX3.48 Million | GBX11.42 Million | GBX2.99 Million | ▼ -70.6% |
| 2013 | 1.04x | GBX10.39 Million | GBX10.03 Million | GBX9.89 Million | ▲ +2.6% |
| 2012 | 1.01x | GBX12.56 Million | GBX12.44 Million | GBX12.56 Million | ▲ +29.1% |
| 2011 | 0.78x | GBX6.82 Million | GBX8.72 Million | GBX6.82 Million | ▼ -23.4% |
| 2010 | 1.02x | GBX15.20 Million | GBX14.89 Million | GBX15.20 Million | ▼ -0.7% |
| 2009 | 1.03x | GBX7.91 Million | GBX7.69 Million | GBX7.91 Million | ▲ +248.3% |
| 2008 | 0.30x | GBX772.00K | GBX2.62 Million | GBX772.00K | ▼ -83.4% |
| 2007 | 1.78x | GBX3.03 Million | GBX1.70 Million | GBX3.03 Million | ▼ -66.9% |
| 2005 | 5.37x | GBX1.93 Million | GBX360.00K | GBX1.93 Million | ▼ -57.1% |
| 2003 | 12.54x | GBX12.24 Million | GBX976.00K | GBX12.24 Million | ▲ +127.9% |
| 2001 | 5.50x | GBX110.00K | GBX20.00K | GBX110.00K | ▲ +50.0% |
| 2000 | 3.67x | GBX1.23 Million | GBX336.00K | GBX1.23 Million | ▲ +561.1% |
| 1999 | 0.55x | GBX766.00K | GBX1.38 Million | GBX766.00K | — |